D.E. Shaw & Co’s Rocket Pharmaceuticals RCKT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.43M Buy
+992,825
New +$2.43M ﹤0.01% 1808
2023
Q3
Sell
-42,215
Closed -$839K 3224
2023
Q2
$839K Sell
42,215
-43,530
-51% -$865K ﹤0.01% 2152
2023
Q1
$1.47M Sell
85,745
-96,417
-53% -$1.65M ﹤0.01% 2003
2022
Q4
$3.56M Sell
182,162
-266,180
-59% -$5.21M ﹤0.01% 1664
2022
Q3
$7.16M Buy
448,342
+260,041
+138% +$4.15M 0.01% 1156
2022
Q2
$2.59M Sell
188,301
-3,211
-2% -$44.2K ﹤0.01% 2086
2022
Q1
$3.04M Buy
191,512
+40,018
+26% +$635K ﹤0.01% 2109
2021
Q4
$3.31M Sell
151,494
-33,940
-18% -$741K ﹤0.01% 2020
2021
Q3
$5.54M Sell
185,434
-14,584
-7% -$436K 0.01% 1397
2021
Q2
$8.86M Sell
200,018
-106,232
-35% -$4.71M 0.01% 1124
2021
Q1
$13.6M Sell
306,250
-12,388
-4% -$550K 0.01% 870
2020
Q4
$17.5M Buy
318,638
+98,759
+45% +$5.42M 0.02% 742
2020
Q3
$5.03M Sell
219,879
-6,323
-3% -$145K 0.01% 1187
2020
Q2
$4.73M Buy
226,202
+18,799
+9% +$393K 0.01% 1190
2020
Q1
$2.89M Buy
207,403
+188,976
+1,026% +$2.64M ﹤0.01% 1333
2019
Q4
$419K Buy
+18,427
New +$419K ﹤0.01% 2254
2019
Q1
Sell
-11,166
Closed -$165K 2697
2018
Q4
$165K Sell
11,166
-13,890
-55% -$205K ﹤0.01% 2412
2018
Q3
$617K Sell
25,056
-32,694
-57% -$805K ﹤0.01% 2006
2018
Q2
$1.13M Sell
57,750
-81,450
-59% -$1.6M ﹤0.01% 1849
2018
Q1
$2.61M Buy
139,200
+14,127
+11% +$265K ﹤0.01% 1383
2017
Q4
$1.31M Buy
125,073
+90,042
+257% +$940K ﹤0.01% 1723
2017
Q3
$249K Buy
35,031
+14,340
+69% +$102K ﹤0.01% 2283
2017
Q2
$157K Sell
20,691
-3,782
-15% -$28.7K ﹤0.01% 2289
2017
Q1
$196K Sell
24,473
-1,384
-5% -$11.1K ﹤0.01% 2289
2016
Q4
$631K Sell
25,857
-24,799
-49% -$605K ﹤0.01% 1937
2016
Q3
$1.92M Buy
50,656
+14,969
+42% +$568K ﹤0.01% 1403
2016
Q2
$1.06M Buy
35,687
+27,476
+335% +$818K ﹤0.01% 1761
2016
Q1
$243K Buy
8,211
+4,550
+124% +$135K ﹤0.01% 2324
2015
Q4
$166K Buy
+3,661
New +$166K ﹤0.01% 2472